Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00350649
Status:
COMPLETED
Last Update Posted:
2011-09-27
First Post:
2006-07-07
Brief Title:
Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cognitive-behavioral coping skills therapy CBT is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders often with emergent effects and continuing improvement even after treatment ends Treatment retention and compliance are associated with enhanced treatment outcomes in CBT Contingency management CM also has very strong support and is associated with rapid robust effects on targeted outcomes Despite their many strengths neither CBT nor CM is universally effective It is now essential to seek strategies to maximize and extend the effectiveness of these two approaches and to better understand how these treatments exert their effects
Detailed Description:
The investigators propose to evaluate targeted strategies to maximize the effectiveness of CBT and CM respectively To maximize the effectiveness of CBT the investigators will evaluate the benefit of adding CM with reinforcement for session attendance and homework completion to standard individual CBT for outpatient marijuana abusers in order to expose participants to more skill training and opportunities for practice of skills To maximize the effectiveness and durability of CM we will evaluate the benefit of integrating it with skills training specifically designed to reduce drop off effects in order to extend CMs benefits beyond the active treatment period We propose to conduct a Stage II trial which will 1 Evaluate the efficacy of four conditions for 160 marijuana dependent outpatients a Standard CBT b CBT with CM reinforcement for attendance and completing homework CBTCMadherence c CM for abstinence alone CMabstinence d CM for abstinence integrated with CBT CMabstinenceCBT and 2 Evaluate the longer-term durability and or delayed emergence of treatment effects after termination of the study treatments through a one-year follow-up Secondary aims will be to conduct a detailed process studies to evaluate whether the proposed enhancements affect proximal and distal outcomes as hypothesized and b economic analyses Study treatments will last 12 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None